Benjamin M Heyman

Trials

Studies that name Benjamin M Heyman as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:36 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07582159 · Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  City of Hope Medical Center · recruiting · Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Small Lymphocytic Lymphoma · principal investigator
• Ph2
  NCT04501939 · Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax

  University of California, San Diego · active not recruiting · Chronic Lymphocytic Leukemia · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 22:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Leadership, Planning and Evaluation
  P30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2004 to 2026
  Named on NCT07582159